NanoViricides Shares Fall Pre-Bell After $3.8 Million Direct Stock Sale Pricing
MT Newswires Live
Jul 24
NanoViricides (NNVC) shares were down more than 11% in Friday's premarket activity after the company said it priced a registered direct offering expected to raise about $3.8 million in gross proceeds.
The company said it entered into a securities purchase agreement with a single institutional investor to sell 2.52 million common shares, or pre-funded warrants in their place, along with warrants to buy an additional 2.52 million shares.
The accompanying warrants have an exercise price of $1.75 per share and will expire five and a half years after issuance, NanoViricides said.
NanoViricides said it expects to close the offering on or about Monday, subject to customary closing conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.